WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2026 Issue has been successfully launched on APRIL 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

MATERNAL AND SYSTEMIC OUTCOMES OF HYPERTENSIVE DISORDERS OF PREGNANCY: A CROSS-SECTIONAL STUDY

*Mohammed Jawad Kadhim Al Shijairi, May Abdul Kareem Jbarah Abu Ragheef

ABSTRACT

Background: Hypertensive disorders of pregnancy are a major cause of maternal and perinatal morbidity and mortality, particularly in low-resource settings, due to delayed diagnosis and inadequate antenatal care. Objectives: To assess maternal systemic manifestations, fetal/neonatal outcomes, and predictors of adverse outcomes among women with hypertensive disorders of pregnancy. Methods: A hospital-based cross-sectional study was conducted on 200 pregnant women (≥20 weeks gestation) with hypertensive disorders of pregnancy at Um Al-Baneen Private Hospital, Baghdad, during 2025. Data on demographic, clinical, laboratory parameters, and maternal and neonatal outcomes were collected. Logistic regression analysis was performed to identify predictors of adverse outcomes. Results: The mean age was 28.3 ± 6.1 years; 28.5% were ≥35 years and 31.5% had no antenatal care. Preeclampsia was the most common subtype (39%), followed by gestational hypertension (26%) and severe preeclampsia (24.5%). Severe hypertension was present in 33.5%, proteinuria in 44%, thrombocytopenia in 17%, elevated liver enzymes in 20.5%, and renal impairment in 14.5%. Systemic complications included hepatic dysfunction (15.5%), ICU admission (13.5%), acute kidney injury (11.5%), and HELLP syndrome (9.5%). Cesarean section was performed in 60.5%, and maternal mortality was 1%. Neonatal outcomes included low birth weight (37%), preterm delivery (34.5%), NICU admission (29%), and low Apgar score (18%). Significant predictors of adverse outcomes included severe hypertension, thrombocytopenia, elevated creatinine, elevated liver enzymes, advanced maternal age, anemia, and inadequate antenatal care (p<0.05). Conclusion: Hypertensive disorders of pregnancy, particularly severe preeclampsia, is associated with substantial maternal and neonatal morbidity. Early detection, adequate antenatal care, and timely management of high-risk cases are essential to improve outcomes.

[Full Text Article] [Download Certificate]